SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

被引：6
|
作者：
Ghosh, Arun K. [1 ,2 ]
Shahabi, Dana [1 ,2 ]
Imhoff, Mackenzie E. C. [3 ]
Kovela, Satish [1 ,2 ]
Sharma, Ashish [1 ,2 ]
Hattori, Shin-ichiro [4 ]
Higashi-Kuwata, Nobuyo [4 ]
Mitsuya, Hiroaki [4 ,5 ,6 ]
Mesecar, Andrew D. [7 ]
机构：
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[4] Natl Ctr Global Hlth & Med, Dept Refractory Viral Dis, Shinjuku Ku, Tokyo 1628655, Japan
[5] Kumamoto Univ Hosp, Dept Clin Sci, Kumamoto 8608556, Japan
[6] Natl Canc Inst, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, Bethesda, MD 20817 USA
[7] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 96卷
关键词：
Antiviral; Covid-19; Inhibitor; SARS-CoV-2; protease; Synthesis;
D O I：
10.1016/j.bmcl.2023.129489
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report here the synthesis and biological evaluation of a series of small molecule SARS-CoV-2 PLpro inhibitors. We compared the activity of selected compounds in both SARS-CoV-1 and SARS-CoV-2 PLpro inhibitory and antiviral assays. We have synthesized and evaluated several new structural variants of previous leads against SARS-CoV-2 PLpro. The replacement of the carboxamide functionality with sulfonamide derivatives resulted in PLpro inhibitors with potent PLpro inhibitory and antiviral activity in VeroE6 cells similar to GRL0617. To obtain molecular insight, we created an optimized model of a potent sulfonamide derivative in the SARS-CoV-2 PLpro active site.
引用
收藏
页数：6
相关论文
共 50 条
  • [11] In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease
    Miwa, Kazunori
    Guo, Yan
    Hata, Masayuki
    Hirano, Yoshinori
    Yamamoto, Norio
    Hoshino, Tyuji
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2023, 71 (12) : 897 - 905
  • [12] SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
    Ershov P.V.
    Yablokov E.O.
    Mezentsev Y.V.
    Chuev G.N.
    Fedotova M.V.
    Kruchinin S.E.
    Ivanov A.S.
    Biophysics, 2022, 67 (6) : 902 - 912
  • [13] Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates
    Jadhav, Prakash
    Liang, Xueying
    Ansari, Ahmadullah
    Tan, Bin
    Tan, Haozhou
    Li, Kan
    Chi, Xiang
    Ford, Alexandra
    Ruiz, Francesc Xavier
    Arnold, Eddy
    Deng, Xufang
    Wang, Jun
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [14] Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach
    Sencanski, Milan
    Perovic, Vladimir
    Milicevic, Jelena
    Todorovic, Tamara
    Prodanovic, Radivoje
    Veljkovic, Veljko
    Paessler, Slobodan
    Glisic, Sanja
    CHEMISTRYOPEN, 2022, 11 (02):
  • [15] Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model
    Garnsey, Michelle R.
    Robinson, Matthew C.
    Nguyen, Luong T.
    Cardin, Rhonda
    Tillotson, Joseph
    Mashalidis, Ellene
    Yu, Aijia
    Aschenbrenner, Lisa
    Balesano, Amanda
    Behzadi, Amin
    Boras, Britton
    Chang, Jeanne S.
    Eng, Heather
    Ephron, Andrew
    Foley, Tim
    Ford, Kristen K.
    Frick, James M.
    Gibson, Scott
    Hao, Li
    Hurst, Brett
    Kalgutkar, Amit S.
    Korczynska, Magdalena
    Lengyel-Zhand, Zsofia
    Gao, Liping
    Meredith, Hannah R.
    Patel, Nandini C.
    Polivkova, Jana
    Rai, Devendra
    Rose, Colin R.
    Rothan, Hussin
    Sakata, Sylvie K.
    Vargo, Thomas R.
    Qi, Wenying
    Wu, Huixian
    Liu, Yiping
    Yurgelonis, Irina
    Zhang, Jinzhi
    Zhu, Yuao
    Zhang, Lei
    Lee, Alpha A.
    SCIENCE ADVANCES, 2024, 10 (35):
  • [16] Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
    Lim, Chew Theng
    Tan, Kang Wei
    Wu, Mary
    Ulferts, Rachel
    Armstrong, Lee A.
    Ozono, Eiko
    Drury, Lucy S.
    Milligan, Jennifer C.
    Zeisner, Theresa U.
    Zeng, Jingkun
    Weissmann, Florian
    Canal, Berta
    Bineva-Todd, Ganka
    Howell, Michael
    O'Reilly, Nicola
    Beale, Rupert
    Kulathu, Yogesh
    Labib, Karim
    Diffley, John F. X.
    BIOCHEMICAL JOURNAL, 2021, 478 (01) : 2517 - 2531
  • [17] Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
    Kawall, Anasha
    Lewis, Devin S. M.
    Sharma, Avini
    Chavada, Krishna
    Deshmukh, Rahul
    Rayalam, Srujana
    Mody, Vicky
    Taval, Shashidharamurthy
    FRONTIERS IN CHEMISTRY, 2023, 10
  • [18] Crystal structure of SARS-CoV-2 papain-like protease
    Gao, Xiaopan
    Qin, Bo
    Chen, Pu
    Zhu, Kaixiang
    Hou, Pengjiao
    Wojdyla, Justyna Aleksandra
    Wang, Meitian
    Cui, Sheng
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (01) : 237 - 245
  • [19] The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease
    Reynolds, Nathanael D.
    Aceves, Nathalie M.
    Liu, Jinny L.
    Compton, Jaimee R.
    Leary, Dagmar H.
    Freitas, Brendan T.
    Pegan, Scott D.
    Doctor, Katarina Z.
    Wu, Fred Y.
    Hu, Xin
    Legler, Patricia M.
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1483 - 1502
  • [20] Crystal structure of SARS-CoV-2 papain-like protease
    Xiaopan Gao
    Bo Qin
    Pu Chen
    Kaixiang Zhu
    Pengjiao Hou
    Justyna Aleksandra Wojdyla
    Meitian Wang
    Sheng Cui
    Acta Pharmaceutica Sinica B, 2021, 11 (01) : 237 - 245
12345